PyInvesting

Market research

4538.TSE Fuso Pharmaceutical Industries,Ltd

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
18B
P/E ratio
8.24
Analyst target
Not available
Dividend yield
4.3%
Beta
0.17

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Fuso Pharmaceutical Industries,Ltd is currently in a long term downtrend where the price is trading 15.3% below its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.

Fuso Pharmaceutical Industries,Ltd's total revenue rose by 5.8% to $13B since the same quarter in the previous year.

Its net income has increased by 33.2% to $377M since the same quarter in the previous year.

Based on the above factors, Fuso Pharmaceutical Industries,Ltd gets an overall score of 3/5.